Vaxxas Initiates Program With Merck to Optimize Delivery of Next Generation Vaccines Utilizing Novel Mechanism for Immune System Activation

You may also like

10 October 2021

Blade Therapeutics Mourns the Passing of General Counsel and Secretary Alan C. Mendelson

21 August 2019

Blade Therapeutics announces publication of preclinical data supporting Calpain 9 as a promising therapeutic target for fibriotic disease

15 November 2020

Clinical Genomics Announces Medicare Coverage Applicable to COLVERA® (Liquid Biopsy Test to Detect Recurrence of Colorectal Cancer)

27 May 2020

Clinical Genomics announces publication of Additional positive data reinforcing key benefits of COLVERA®

29 May 2017

OneVentures Boosts Healthcare Team

16 March 2020

OneVentures invests in international software company Phocas, bringing business back to Australia and positioning the company for international expansion

View All

Ventured. Gained.

Subscribe to our Newsletter for the latest updates from 1V.

decor decor decor
decor decor decor decor decor
clear Close